Read the full press release here Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Catalent, Inc., the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced the expansion of their strategic collaboration to dedicate a […]
A new report from the Wisconsin Economic Development Corporation (WEDC) sets out a comprehensive strategy for investing in people to help Wisconsin recover from the economic impact of the COVID-19 pandemic, WEDC Secretary and CEO Missy Hughes announced today. The report, Wisconsin Tomorrow: Building an Economy for All, is intended to help guide the state’s use […]
Read the full press release here GE Healthcare recently launched a point-of-care ultrasound (POCUS) system, as well as an industry-first artificial intelligence (AI) offering for cardiac imaging on the Venue and Venue Go. The offering, called the Venue Fit, is the smallest system in GE’s Venue Family. The system features a touchscreen, scanning tools, and a small […]
Learn more & register here Join us virtually to learn about venture capital, the winnow fund, and other interesting topics that impact Biotech in Wisconsin!
Read the full press release here The Wisconsin Alumni Research Foundation announced that four projects have been selected to receive development funding through the WARF Accelerator Microbiome Challenge Grant. From infection-fighting probiotics to methods for managing mosquito populations, these technologies have high potential impact. Researchers representing 20 departments and centers applied for the grant. The selected […]
Read the full press release here In participants aged 12-15 years old, BNT162b2 demonstrated 100% efficacy and robust antibody responses, exceeding those reported in trial of vaccinated 16-25 year old participants in an earlier analysis, and was well tolerated The companies plan to submit these data to the U.S. Food and Drug Administration (FDA) and […]
Read the full press release here Stem Pharm, Inc. has been awarded a $1.7 million SBIR grant from the National Institute of Environmental Health Sciences of the National Institutes of Health (NIH) to optimize its induced pluripotent stem cell (iPSC)-derived model of the central nervous system for drug discovery and toxicology applications. Stem Pharm’s model […]
Learn more & apply here Thank You to Wisconsin Economic Development Corporation’s International Division BioForward is able to provide Small Business scholarships to Wisconsin Biohealth companies based on need. Small Business Scholarship funding is provided through the support of the Wisconsin Economic Development Corporation and is a benefit of BioForward membership. This year the Small […]
Read the full press release here JANESVILLE, Wis., March 25, 2021 – SHINE Medical Technologies LLC today announced that construction of the exterior structure of its first-of-a-kind medical isotope production facility is complete and the building is weathertight, a major milestone with significance for SHINE, the medical isotope industry and patients around the world. Reaching […]
Read the full press release Scientists at the University of Wisconsin-Madison have developed a way to use a cell’s own recycling machinery to destroy disease-causing proteins, a technology that could produce entirely new kinds of drugs. Some cancers, for instance, are associated with abnormal proteins or an excess of normally harmless proteins. By eliminating them, […]